|
Volumn 148, Issue 2, 2008, Pages 162-163
|
Comparative effectiveness of treatments for rheumatoid arthritis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABATACEPT;
CORTICOSTEROID;
DISEASE MODIFYING ANTIRHEUMATIC DRUG;
HYDROXYCHLOROQUINE;
LEFLUNOMIDE;
METHOTREXATE;
NONSTEROID ANTIINFLAMMATORY AGENT;
RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
RITUXIMAB;
SALAZOSULFAPYRIDINE;
TUMOR NECROSIS FACTOR ANTIBODY;
ANTIRHEUMATIC AGENT;
BIOLOGICAL PRODUCT;
CLINICAL TRIAL;
DISEASE ACTIVITY;
DRUG EFFICACY;
EDITORIAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LOW DRUG DOSE;
MONOTHERAPY;
PATIENT CARE;
PATIENT MONITORING;
PHYSIOTHERAPY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
REMISSION;
RHEUMATOID ARTHRITIS;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
DRUG COMBINATION;
NOTE;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
BIOLOGICAL PRODUCTS;
DRUG THERAPY, COMBINATION;
HUMANS;
PRACTICE GUIDELINES AS TOPIC;
TREATMENT OUTCOME;
|
EID: 38749125577
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-148-2-200801150-00012 Document Type: Editorial |
Times cited : (12)
|
References (14)
|